Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Prilenia
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Pride HD completion within the last 6 months, including 2 week follow up period or patients who transitioned from the Open HART study or patients who complete future safety and efficacy clinical trials of pridopidine. In addition, patients who have already completed their defined study period under Open PRIDE HD global or local amendments and have discontinued treatment with pridopidine will be allowed to re enter the Open PRIDE HD study.
Women of child bearing potential or male participants: Adequate contraception and birth control
Good general health
* other criteria apply, please contact the investigator for more information
You may not be if
Similar baseline criteria for ECG, vital signs, cardiovascular system, and renal function to PRIDE HD;
Similar concomitant medication restrictions to PRIDE HD.
* other criteria apply, please contact the investigator for more information
Clareo Health | A Study Evaluating if Pridopidine is Safe, Efficacious, and Tolerable in Patients With Huntington's Disease
